Cargando…

Use of immunomagnetic reduction for C-reactive protein assay in clinical samples

BACKGROUND: Magnetic nanoparticles biofunctionalized with antibodies are able to recognize and bind to the corresponding antigens. In this work, anti-C-reactive protein (CRP) antibody was covalently conjugated onto the surface of magnetic nanoparticles to label CRP specifically in serum. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Chien-Hsi, Lai, Zhi-Xian, Lin, Hsiu-Li, Yang, Che-Chuan, Chen, Hsin-Hsien, Yang, Shieh-Yueh, Horng, Herng-Er, Hong, Chin-Yih, Yang, Hong-Chang, Lin, Hsiu-Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419507/ https://www.ncbi.nlm.nih.gov/pubmed/22915855 http://dx.doi.org/10.2147/IJN.S31030

Ejemplares similares

Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer’s Disease
por: Yang, Shieh-Yueh, et al.
Publicado: (2017)

Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology
por: Liu, Huei-Chun, et al.
Publicado: (2020)

Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles
por: Huang, Kai-Wen, et al.
Publicado: (2012)

Development of a 36-Channel Instrument for Assaying Biomarkers of Ultralow Concentrations Utilizing Immunomagnetic Reduction
por: Chen, Hsin-Hsien, et al.
Publicado: (2022)

Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles
por: Yang, Shieh-Yueh, et al.
Publicado: (2016)

Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
por: Lin, Chin-Hsien, et al.
Publicado: (2017)

Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
por: Lin, Chin-Hsien, et al.
Publicado: (2018)

Investigation of the Number of Tests Required for Assaying Plasma Biomarkers Associated with Alzheimer’s Disease Using Immunomagnetic Reduction
por: Liu, Huei-Chun, et al.
Publicado: (2021)

A Novel Detection Platform for Shrimp White Spot Syndrome Virus Using an ICP11-Dependent Immunomagnetic Reduction (IMR) Assay
por: Liu, Bing-Hsien, et al.
Publicado: (2015)

Discriminating Hepatocellular Carcinoma in Rats Using a High-T(c) SQUID Detected Nuclear Resonance Spectrometer in a Magnetic Shielding Box
por: Huang, Kai-Wen, et al.
Publicado: (2012)

Correction: Discriminating Hepatocellular Carcinoma in Rats Using a High-T(c) SQUID Detected Nuclear Resonance Spectrometer in a Magnetic Shielding Box
por: Huang, Kai-Wen, et al.
Publicado: (2014)

Anti-CEA-functionalized superparamagnetic iron oxide nanoparticles for examining colorectal tumors in vivo
por: Huang, Kai-Wen, et al.
Publicado: (2013)

Characteristics of magnetic labeling on liver tumors with anti-alpha-fetoprotein-mediated Fe(3)O(4) magnetic nanoparticles
por: Huang, Kai-Wen, et al.
Publicado: (2012)

Immunomagnetic Reduction Detects Plasma Aβ(1–42) Levels as a Potential Dominant Indicator Predicting Cognitive Decline
por: Yang, Shieh-Yueh, et al.
Publicado: (2020)

Applications of Immunomagnetic Reduction Technology as a Biosensor in Therapeutic Evaluation of Chinese Herbal Medicine in Tauopathy Alleviation of an AD Drosophila Model
por: Su, Ming-Tsan, et al.
Publicado: (2022)

In Vivo Screening of Hepatocellular Carcinoma Using AC Susceptibility of Anti-Alpha Fetoprotein-Activated Magnetic Nanoparticles
por: Chieh, Jen-Jie, et al.
Publicado: (2012)

Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases
por: Yang, Shieh-Yueh, et al.
Publicado: (2017)

Long-Term Storage Effects on Stability of Aβ(1–40), Aβ(1–42), and Total Tau Proteins in Human Plasma Samples Measured with Immunomagnetic Reduction Assays
por: Chiu, Ming-Jang, et al.
Publicado: (2019)

Multilevel calcium pyrophosphate dihydrate deposition in cervical ligamentum flavum: clinical characteristics and imaging features
por: Lu, Yueh-Hsiu, et al.
Publicado: (2021)

Immunomagnetic nanoparticle-based assays for detection of biomarkers
por: Park, Hoyoung, et al.
Publicado: (2013)

Eight-Channel AC Magnetosusceptometer of Magnetic Nanoparticles for High-Throughput and Ultra-High-Sensitivity Immunoassay
por: Chieh, Jen-Jie, et al.
Publicado: (2018)

Magnetic Clustering Effect during the Association of Biofunctionalized Magnetic Nanoparticles with Biomarkers
por: Chen, Kuen-Lin, et al.
Publicado: (2015)

A Noninvasive Method to Determine the Fate of Fe(3)O(4) Nanoparticles following Intravenous Injection Using Scanning SQUID Biosusceptometry
por: Tseng, Wei-Kung, et al.
Publicado: (2012)

Classification of patients with Alzheimer’s disease using the arterial pulse spectrum and a multilayer-perceptron analysis
por: Lin, Shun-Ku, et al.
Publicado: (2021)

Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease
por: Chang, Chun-Wei, et al.
Publicado: (2020)

Immunoliposome-based fluorometric patulin assay by using immunomagnetic nanoparticles
por: Song, Xinjie, et al.
Publicado: (2019)

Spatial Repolarization Heterogeneity Detected by Magnetocardiography Correlates with Cardiac Iron Overload and Adverse Cardiac Events in Beta-Thalassemia Major
por: Chen, Chun-An, et al.
Publicado: (2014)

Validation of Assaying Carcinoembryonic Antigen in Human Serum by Using Immunomagnetic Reduction
por: Wei, Po-Li, et al.
Publicado: (2018)

Association between faecal haemoglobin concentration and the risk of cardiovascular diseases among Taiwanese adults in a community-based screening cohort
por: Chien, Kuo-Liong, et al.
Publicado: (2020)

Using Bio-Functionalized Magnetic Nanoparticles and Dynamic Nuclear Magnetic Resonance to Characterize the Time-Dependent Spin-Spin Relaxation Time for Sensitive Bio-Detection
por: Liao, Shu-Hsien, et al.
Publicado: (2014)

Innovative strategy with potential to increase hemodialysis efficiency and safety
por: Chen, Hsiao-Chien, et al.
Publicado: (2014)

Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease
por: Chen, Nai-Ching, et al.
Publicado: (2020)

Enhanced Competitive Immunomagnetic Beads Assay Assisted with PAMAM-Gold Nanoparticles Multi-Enzyme Probes for Detection of Deoxynivalenol
por: Zeng, Kun, et al.
Publicado: (2023)

Integrated Immunomagnetic Bead-Based Microfluidic Chip for Exosomes Isolation
por: Niu, Fuzhou, et al.
Publicado: (2020)

Diagnosis and Treatment of Central Serous Chorioretinopathy in Patients with Scleritis
por: Tsai, Yu-Chien, et al.
Publicado: (2023)

Tomatidine Represses Invasion and Migration of Human Osteosarcoma U2OS and HOS Cells by Suppression of Presenilin 1 and c-Raf–MEK–ERK Pathway
por: Hsieh, Min-Hong, et al.
Publicado: (2020)

Multiplex Immunoassays Utilizing Differential Affinity Using Aptamers Generated by MARAS
por: Lai, Ji-Ching, et al.
Publicado: (2017)

Study of Orofacial Function in Preschool Children Born Prematurely
por: Chang, Mei-Chen, et al.
Publicado: (2022)

Ratio of C-Reactive Protein to Albumin Predicts Muscle Mass in Adult Patients Undergoing Hemodialysis
por: Wong, Te-Chih, et al.
Publicado: (2016)

Effect of Time to Detection on the Measured Concentrations of Blood Proteins Associated with Alzheimer's Disease
por: Chen, Hsin-Hsien, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g998bn2kbv6lgdmq3i2p4ipmci